Matches in Wikidata for { <http://www.wikidata.org/entity/Q64790416> ?p ?o ?g. }
Showing items 1 to 50 of
50
with 100 items per page.
- Q64790416 description "clinical trial" @default.
- Q64790416 description "ensayu clínicu" @default.
- Q64790416 description "klinisch onderzoek" @default.
- Q64790416 description "клінічне випробування" @default.
- Q64790416 name "WAveCrest Vs. Watchman TranssEptal LAA Closure to REduce AF-Mediated STroke 2" @default.
- Q64790416 type Item @default.
- Q64790416 label "WAveCrest Vs. Watchman TranssEptal LAA Closure to REduce AF-Mediated STroke 2" @default.
- Q64790416 prefLabel "WAveCrest Vs. Watchman TranssEptal LAA Closure to REduce AF-Mediated STroke 2" @default.
- Q64790416 P1050 Q64790416-B56B0FD0-4DD7-42BE-B72A-05FE29AF62FE @default.
- Q64790416 P1050 Q64790416-F1596291-CD9E-4ECD-8637-F070368CFBE4 @default.
- Q64790416 P1132 Q64790416-829D8C8E-07BF-49EF-AAC1-B2F2688B0BE1 @default.
- Q64790416 P1476 Q64790416-7C973DF0-73D0-4A2C-A3FE-35820C0A116E @default.
- Q64790416 P17 Q64790416-2DC44792-9D13-4C66-AFD3-FFB1FAD22C7B @default.
- Q64790416 P1813 Q64790416-90DCBF36-F3E8-493E-9E8B-0A10EC443199 @default.
- Q64790416 P2899 Q64790416-08B1A1BE-3370-4684-854E-CC194430BA5B @default.
- Q64790416 P3098 Q64790416-2BE009BE-1DC0-49CA-8410-309D2EF77ED9 @default.
- Q64790416 P31 Q64790416-0FF6DDAB-B91D-4ABF-BB31-C49ABFB38A69 @default.
- Q64790416 P580 Q64790416-56C974FB-BECD-49A7-8FB5-3B8C1C1A4153 @default.
- Q64790416 P582 Q64790416-D88AFE73-6330-4981-8562-1F84B70BA10E @default.
- Q64790416 P6099 Q64790416-CAF34656-96D0-480B-AC2F-0049A1DC4D2F @default.
- Q64790416 P6153 Q64790416-10E81241-9E8F-4DAF-A311-78E67D7C2D3D @default.
- Q64790416 P6153 Q64790416-1EF8C1EA-FB60-411D-86EB-DD3ECEF51BEE @default.
- Q64790416 P6153 Q64790416-2AF037E7-682F-4EFB-9FF2-60876B929D64 @default.
- Q64790416 P6153 Q64790416-3FF9CB21-CAE3-466D-A0CF-B593BAE17D5F @default.
- Q64790416 P6153 Q64790416-95B3A5D4-535A-49D2-9E46-406BF327E02A @default.
- Q64790416 P6153 Q64790416-CA9AA109-87AA-402E-BA5C-5B821863816F @default.
- Q64790416 P6153 Q64790416-D8677D07-27DD-4C10-B7CE-6EA8CD75D247 @default.
- Q64790416 P6153 Q64790416-E73A2AFD-970B-492F-9AED-91C8BD15757C @default.
- Q64790416 P8363 Q64790416-CB6CA5A3-7E34-4E0E-B687-7E79D1537C6C @default.
- Q64790416 P1050 Q12202 @default.
- Q64790416 P1050 Q815819 @default.
- Q64790416 P1132 "+1250" @default.
- Q64790416 P1476 "WAveCrest Vs. Watchman TranssEptal LAA Closure to REduce AF-Mediated STroke 2. A Prospective, Multicenter, Randomized, Active Controlled, Clinical Trial of the Coherex WaveCrest® Left Atrial Appendage Occlusion System Compared to the Watchman® LAA Closure Device for the Reduction in Risk of Ischemic Stroke or Systemic Embolism in Subjects With Non-valvular Atrial Fibrillation That Have an Appropriate Rationale to Seek a Non-pharmacologic Alternative to Chronic Oral Anticoagulation." @default.
- Q64790416 P17 Q30 @default.
- Q64790416 P1813 "WAVECREST2" @default.
- Q64790416 P2899 "+18" @default.
- Q64790416 P3098 "NCT03302494" @default.
- Q64790416 P31 Q30612 @default.
- Q64790416 P580 "2017-12-28T00:00:00Z" @default.
- Q64790416 P582 "2020-12-01T00:00:00Z" @default.
- Q64790416 P6099 Q42824827 @default.
- Q64790416 P6153 Q1950740 @default.
- Q64790416 P6153 Q2303536 @default.
- Q64790416 P6153 Q309331 @default.
- Q64790416 P6153 Q33122159 @default.
- Q64790416 P6153 Q49210 @default.
- Q64790416 P6153 Q598841 @default.
- Q64790416 P6153 Q6936903 @default.
- Q64790416 P6153 Q7592067 @default.
- Q64790416 P8363 Q78089383 @default.